| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |